Bronson Crouch
Chief Executive Officer at INSTIL BIO, INC.
Net worth: 22 M $ as of 29/04/2024
Bronson Crouch active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INSTIL BIO, INC. | Chairman | 31/10/2018 | - |
| Chief Executive Officer | 31/10/2018 | - | |
| Director/Board Member | 31/10/2018 | - | |
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
| PELOTON THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Curative Ventures Management LLC
 Curative Ventures Management LLC Investment ManagersFinance Curative Ventures Management LLC (Curative Ventures) is a venture capital firm founded in 2010. The firm is headquartered in Dallas, Texas. | Private Equity Investor | 31/12/2013 | - |
Career history of Bronson Crouch
Former positions of Bronson Crouch
| Companies | Position | Start | End |
|---|---|---|---|
| ITEOS THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Statistics
International
| United States | 7 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 6 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX. | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Curative Ventures Management LLC
Curative Ventures Management LLC Investment ManagersFinance Curative Ventures Management LLC (Curative Ventures) is a venture capital firm founded in 2010. The firm is headquartered in Dallas, Texas. | Finance |
- Stock Market
- Insiders
- Bronson Crouch
- Experience
